newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Reports Third Quarter 2020 Financial and Operating Results

CAMBRIDGE, Ma., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative...